Evidence map›Paper›PMID 33940263›Full record

ArticleWorld neurosurgery2021

Subarachnoid Hemorrhage and COVID-19: An Analysis of 282,718 Patients.

Adnan I Qureshi, William I Baskett, Wei Huang, Daniel Shyu, Danny Myers, Iryna Lobanova, Muhammad F Ishfaq, S Hasan Naqvi, Brandi R French, Farhan Siddiq and 2 more

Abstract readMulticenter Study
In one paragraph

Article in World neurosurgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Characteristics of subarachnoid hemorrhage associated with COVID-19 infection: A systematic review and descriptive analysis.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2023
    Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Cerebrovascular Manifestations of SARS-CoV-2: A Comprehensive Review.Current treatment options in neurology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Utilization and Outcomes of Acute Revascularization Treatments in Ischemic Stroke Patients with SARS-CoV-2 Infection.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2022
    Article
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Adnan I QureshiZeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, Missouri, USA.
William I BaskettInstitute for Data Science and Informatics, University of Missouri, Columbia, Missouri, USA.
Wei HuangZeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, Missouri, USA.
Daniel ShyuDepartment of Medicine, University of Missouri, Columbia, Missouri, USA.
Danny MyersTiger Institute for Health Innovation, Cerner Corporation, Columbia, Missouri, USA.
Iryna LobanovaZeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, Missouri, USA. Electronic address: lobanovanmu@gmail.com.
Muhammad F IshfaqZeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, Missouri, USA.
S Hasan NaqviDepartment of Medicine, University of Missouri, Columbia, Missouri, USA.
Brandi R FrenchZeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, Missouri, USA.
Farhan SiddiqDivision of Neurosurgery, University of Missouri, Columbia, Missouri, USA.
Camilo R GomezZeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, Missouri, USA.
Chi-Ren ShyuInstitute for Data Science and Informatics, University of Missouri, Columbia, Missouri, USA; Department of Medicine, University of Missouri, Columbia, Missouri, USA; Department of Electrical Engineering and Computer Science, University of Missouri, Columbia, Missouri, USA.

Funding

Massive and Complex Data Analytics Pre-Doctoral Training in One HealthT32LM012410 · NLM · UNIVERSITY OF MISSOURI-COLUMBIA · PI SHYU, CHI-REN · 2016 to 2020
$1.2M
NLM NIH HHS T32 LM012410
6 · The paper itself

Abstract

backgroundIntracranial hemorrhage (including subarachnoid hemorrhage [SAH]) has been reported in 0.3%-1.2% of patients with coronavirus disease 2019 (COVID-19). However, no study has evaluated the risk of SAH in patients with COVID-19.

methodsWe analyzed data from 62 health care facilities using the Cerner de-identified COVID-19 dataset.

resultsThere were 86 (0.1%) and 376 (0.2%) patients with SAH among 85,645 patients with COVID-19 and 197,073 patients without COVID-19, respectively. In the multivariate model, there was a lower risk of SAH in patients with COVID-19 (odds ratio 0.5, 95% confidence interval 0.4-0.7, P < 0.0001) after adjusting for sex, age strata, race/ethnicity, hypertension, and nicotine dependence/tobacco use. The proportions of patients who developed pneumonia (58.1% vs. 21.3%, P < 0.0001), acute kidney injury (43% vs. 27.7%, P = 0.0005), septic shock (44.2% vs. 20.7%, P < 0.0001), and respiratory failure (64.0% vs. 39.1%, P < 0.0001) were significantly higher among patients with SAH and COVID-19 compared with patients without COVID-19. The in-hospital mortality among patients with SAH and COVID-19 was significantly higher compared with patients without COVID-19 (31.4% vs. 12.2%, P < 0.0001).

conclusionsThe risk of SAH was not increased in patients with COVID-19. The higher mortality in patients with SAH and COVID-19 compared with patients without COVID-19 is likely mediated by higher frequency of systemic comorbidities.

Indexed as

Databases, FactualAdultAgedCOVID-19FemaleHumansMaleMiddle AgedMortalitySubarachnoid HemorrhageCOVID-19DeathDisabilityElectronic medical recordsSARS-CoV-2Subarachnoid hemorrhage

Identifiers

PMID33940263
PMCPMC8086384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.